Filing Details

Accession Number:
0001127602-16-068954
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-02 15:00:47
Reporting Period:
2016-12-01
Filing Date:
2016-12-02
Accepted Time:
2016-12-02 15:00:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472091 Edge Therapeutics Inc. EDGE Pharmaceutical Preparations (2834) 264231384
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652973 A Brian Leuthner 300 Connell Drive,
Suite 4000
Berkeley Heights NJ 07922
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-01 7,500 $11.60 252,979 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 275,479 Indirect By Spouse
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $11.11 to $12.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.